Suchergebnisse - "Battisti, Nicolò Matteo Luca"

PubPharm (7)

1

Chemotherapy and gene expression profiling in older early luminal breast cancer patients : An International Society of Geriatric Oncology systematic review

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Battisti, N. | De Glas, N. | Soto-Perez-de-Celis, E. | +11

2

Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer

enthalten in: Breast cancer research and treatment | 2021

von Battisti, N. | Andres, M. | Lee, K. | +16

3

The Conundrum of the Association of Chemotherapy With Survival Outcomes Among Elderly Patients With Curable Luminal Breast Cancer

enthalten in: JAMA oncology | 2020

von Battisti, N. | McCartney, A. | Biganzoli, L.

CommentOn: JAMA Oncol. 2020 Oct 1;6(10):1548-1554. - PMID 32672820

4

Safety and efficacy of T-DM1 in patients with advanced HER2-positive breast cancer The Royal Marsden experience

enthalten in: Cancer treatment and research communications | 2020

von Battisti, N. | Rogerson, F. | Lee, K. | +9

5

Long-term outcome with targeted therapy in advanced/metastatic HER2-positive breast cancer : The Royal Marsden experience

enthalten in: Breast cancer research and treatment | 2019

von Battisti, N. | Tong, D. | Ring, A. | +1

6

Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer : the UK Compassionate Access Programme experience

enthalten in: Breast cancer research and treatment | 2019

von Battisti, N. | Kingston, B. | King, J. | +17

7

Targeted agents for HER2-positive breast cancer in older adults : current and future perspectives

enthalten in: Expert opinion on investigational drugs | 2018

von Soto-Perez-De-Celis, E. | Loh, K. | Baldini, C. | +5

1
[1]